Ordinary Index Rebalancing in the Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index | April 2021

In the ordinary rebalance the following composition will be implemented effective open 06.04.2021:

ABBVIE INC
ASTRAZENECA PLC
BRISTOL-MYERS SQUIBB CO
JOHNSON & JOHNSON
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
PFIZER INC
ROCHE HOLDING AG
SANOFI SA